Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Service de Génétique Médicale, |
RCV005233091 | SCV005880178 | likely pathogenic | Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | 2024-02-27 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV002574468 | SCV003489135 | uncertain significance | Progressive sclerosing poliodystrophy | 2025-05-22 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 877 of the POLG protein (p.Met877Val). This variant is present in population databases (rs754025885, gnomAD 0.003%). This missense change has been observed in individual(s) with POLG-related condition (PMID: 38703036). ClinVar contains an entry for this variant (Variation ID: 2172898). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt POLG protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |